AGP Executive Report

Last update: 2 hours ago

Bilateral Investment Treaty Talks: India’s Finance Minister Nirmala Sitharaman met Swiss President Guy Parmelin to push forward negotiations on a Bilateral Investment Treaty, aiming to boost investment flows and deepen economic ties. Trade & Health-Relevant Sectors: The wider India–Switzerland push also highlights cooperation in infrastructure, technology, innovation, and supply chains, with TEPA (India–EFTA) framed as a jobs-and-investment engine. Mobility & People-to-People Links: Modi and Parmelin signed a migration and mobility partnership plus a young professionals exchange, including longer-duration visas and easier movement for students and skilled workers. EU Health Innovation in the Region: The EU granted marketing authorisation for Nezglyal for childhood cerebral adrenoleukodystrophy (cALD), described as the first pharmacological option for early intervention. Policy Watch (Liechtenstein): The European Evangelical Alliance raised concerns after Liechtenstein’s parliament narrowly backed a citizen-led initiative to legalize abortion in the first 12 weeks. Access to Care via Travel: DiscoverEU applications opened for 40,000 free train passes for 18-year-olds, including eligible participants from Liechtenstein.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Sep. 7, 2026

Swiss parabolic flight campaign pivots toward commercial space applications

AGP

fallback image
Jul. 3, 2026

European Commission authorizes CinnaGen’s osteoporosis biosimilar Zandoriah in EU

AGP

fallback image
Jul. 28, 2026

The European releases its Summer 2026 edition

AGP

fallback image
Jul. 2, 2026

American Swiss Foundation honors Adrian Keller at leadership dinner in Rüschlikon

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Press Release Service Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Press Release Service
Indeterminate
Pharma tariffs reach smaller drugmakers as industry warns of R&D pressure

Pharma tariffs reach smaller drugmakers as industry warns of R&D pressure

European evangelical body raises concerns over abortion measures in Andorra and Liechtenstein

European evangelical body raises concerns over abortion measures in Andorra and Liechtenstein

Pharmaceutical Section 232 Tariffs: U.S. Department of Commerce Clarifies Specialty Drug Exemptions Before September 29 Deadline

Pharmaceutical Section 232 Tariffs: U.S. Department of Commerce Clarifies Specialty Drug Exemptions Before September 29 Deadline

US waives 100 pc tariff on select Indian speciality drugs: What it means for pharma industry

US waives 100 pc tariff on select Indian speciality drugs: What it means for pharma industry

Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speciality drugs

Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speciality drugs


fallback image
Sep. 25, 2026

European Commission grants marketing authorisation for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease

GlobeNewswire, Inc.

fallback image
Sep. 18, 2026

Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome

GlobeNewswire, Inc.

fallback image
Jul. 23, 2026

Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing

GlobeNewswire, Inc.

fallback image
Jul. 24, 2026

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

GlobeNewswire, Inc.

fallback image
Jul. 1, 2026

SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma

GlobeNewswire, Inc.

fallback image
May 19, 2026

SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: This Industry Adds €65 Billion to the European Economy, but is its bad Reputation Fair?
Play
This Industry Adds €65 Billion to the European Economy, but is its bad Reputation Fair?
YouTube video thumbnail: Schools Shut as Student Protests Shake France
Play
Schools Shut as Student Protests Shake France
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: Could Russia's Deadly Plague lab Incident Spark Another Pandemic?
Play
Could Russia's Deadly Plague lab Incident Spark Another Pandemic?
YouTube video thumbnail: How an 87-Year-Old's Eviction Triggered an Election
Play
How an 87-Year-Old's Eviction Triggered an Election

Video Title

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.